ImmunoSEQ hsTCRB v4 assay

Closed Pre-Solicitation Posted

Solicitation number
75N92019Q0145
Agency
National Heart Lung and Blood Institute National Institutes of Health, Department of Health and Human Services
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
Not on record
Place of performance
NIH Main CampusResearch Clinical CenterBld 10 RM 13C217BethesdaMD20892USA 20892 USA
More information

Notice details come from SAM.gov. Updated .

Notice text

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Heart, Lung, and Blood Institute (NHLBI), Office of Acquisitions (OA) on behalf of the National Institute of Arthritus and Musculoskelteal and Skin Diseases (NIAMS) intends to negotiate and award a Purchase Order without providing for full and open competition to Adaptive Biotechnologies Corp for the procurement of 30 immunoSEQ hsTCRB v4 assays to quantitatively assess the breadth and complexity of clonal T- or B-cell populations in 30 blood samples to help screen healthy controls and scleroderma patients..

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity